123 related articles for article (PubMed ID: 32830134)
1. [A Case of Miliary Brain Metastases Molecularly Diagnosed as Silent Lung Adenocarcinoma Origin].
Nagai T; Takeuchi H; Kamata K; Kawabe T; Takahashi Y; Hashimoto N
No Shinkei Geka; 2020 Aug; 48(8):701-706. PubMed ID: 32830134
[TBL] [Abstract][Full Text] [Related]
2. [Miliary cerebral carcinomatosis secondary to EGFR mutation-positive lung adenocarcinoma].
Dumoulin J; Rozensztajn N; Paradis M; Sellier J; Abel A; Giraud P; Labrune S; Chinet T
Rev Mal Respir; 2016 Jan; 33(1):67-71. PubMed ID: 25794997
[TBL] [Abstract][Full Text] [Related]
3. Folliculotropic Cutaneous Metastases and Lymphangitis Carcinomatosa: When Cutaneous Metastases of Breast Carcinoma Are Mistaken for Cutaneous Infections.
Paolino G; Panetta C; Didona D; Donati M; Donati P
Acta Dermatovenerol Croat; 2016 Jun; 24(2):154-7. PubMed ID: 27477179
[TBL] [Abstract][Full Text] [Related]
4. Cytokeratin 7-positive/cytokeratin 20-negative cecal adenocarcinoma metastatic to the uterine cervix: a case report.
Toyoshima M; Momono Y; Makino H; Kudo T; Oka N; Sakurada J; Suzuki H; Kodama H; Yoshinaga K
World J Surg Oncol; 2016 Jan; 14(1):22. PubMed ID: 26810414
[TBL] [Abstract][Full Text] [Related]
5. An ALK-positive lung adenocarcinoma with gastric and skin metastasis: a case report and literature review.
Duan X; Zhao X; Wang S
Ann Palliat Med; 2021 May; 10(5):5797-5807. PubMed ID: 32819126
[TBL] [Abstract][Full Text] [Related]
6. Targeted therapy of multiple liver metastases after resected solitary gastric metastasis and primary pulmonary adenocarcinoma.
Ding LY; Liu KJ; Jiang ZL; Wu HY; Wu SX
Oncotarget; 2016 Dec; 7(52):87479-87484. PubMed ID: 27829227
[TBL] [Abstract][Full Text] [Related]
7. [Abdominal lymph node metastases detected five years after surgery for the lung cancer; report of a case].
Watanabe N; Iwazawa T; Nagai K; Miyake M; Hata T; Kawanishi K; Fujita J; Akagi K; Dono K; Nishioka K; Adachi S; Kitada M
Kyobu Geka; 2012 Apr; 65(4):341-3. PubMed ID: 22485042
[TBL] [Abstract][Full Text] [Related]
8. Use of thyroid transcription factor 1, PE-10, and cytokeratins 7 and 20 in discriminating between primary lung carcinomas and metastatic lesions in fine-needle aspiration biopsy specimens.
Chhieng DC; Cangiarella JF; Zakowski MF; Goswami S; Cohen JM; Yee HT
Cancer; 2001 Oct; 93(5):330-6. PubMed ID: 11668468
[TBL] [Abstract][Full Text] [Related]
9. Ovarian metastases from
Li H; Chen Y; Wang Y; Zhou L; Tian Z; Liu M; Li Y; Xu H; Wu W; Gong Z
Transl Cancer Res; 2022 Sep; 11(9):3391-3399. PubMed ID: 36237252
[TBL] [Abstract][Full Text] [Related]
10. Concordant clear cell "mesonephric" carcinoma of the bladder and lung adenocarcinoma with clear cell features - multiple primaries versus metastatic neoplasms: a case report.
Jassim SH; Khiyami A; Nguyen JK; Ganesan S; Tomashefski J; Sawady J
J Med Case Rep; 2017 May; 11(1):133. PubMed ID: 28494807
[TBL] [Abstract][Full Text] [Related]
11. CDX-2 Expression in Primary Lung Adenocarcinoma.
Cowan ML; Li QK; Illei PB
Appl Immunohistochem Mol Morphol; 2016 Jan; 24(1):16-9. PubMed ID: 26469326
[TBL] [Abstract][Full Text] [Related]
12. Sister Mary Joseph's nodule as a presenting sign of internal malignancy.
Dodiuk-Gad R; Ziv M; Loven D; Schafer J; Shani-Adir A; Dyachenko P; Rozenman D
Skinmed; 2006; 5(5):256-8. PubMed ID: 16957443
[TBL] [Abstract][Full Text] [Related]
13. Identification of a metastatic lung adenocarcinoma of the palate mucosa through genetic and histopathological analysis: a rare case report and literature review.
Abe M; Watanabe K; Shinozaki-Ushiku A; Ushiku T; Abe T; Fujihara Y; Amano Y; Zong L; Wang CP; Kubo E; Inaki R; Kinoshita N; Yamashita S; Takai D; Ushijima T; Nagase T; Hoshi K
BMC Cancer; 2019 Jan; 19(1):52. PubMed ID: 30634950
[TBL] [Abstract][Full Text] [Related]
14. Miliary brain metastases from lung adenocarcinoma as non-enhancing lesions on MRI: a case report and literature review.
Huang Z; Xie D; Yang P; Song E; Zhang J; Chen J; Qin F
Transl Cancer Res; 2021 Feb; 10(2):1162-1168. PubMed ID: 35116443
[TBL] [Abstract][Full Text] [Related]
15. Clinical Response to Apatinib Combined With Brain Radiotherapy in EGFR Wild-Type and ALK-Negative Lung Adenocarcinoma With Multiple Brain Metastases.
Ying X; Liu H; Wang M; Peng M; Ruan P; Verma V; Han G
Front Oncol; 2020; 10():517. PubMed ID: 32351894
[No Abstract] [Full Text] [Related]
16. Treatment of Brain Metastases of Non-Small Cell Lung Carcinoma.
Rybarczyk-Kasiuchnicz A; Ramlau R; Stencel K
Int J Mol Sci; 2021 Jan; 22(2):. PubMed ID: 33435596
[TBL] [Abstract][Full Text] [Related]
17. Miliary pattern on chest imaging as a presentation of EGFR-negative primary lung adenocarcinoma.
Hoffman SA; Manski S; Deepak J
BMJ Case Rep; 2019 May; 12(5):. PubMed ID: 31151972
[TBL] [Abstract][Full Text] [Related]
18. Recurrence of lung adenocarcinoma after an interval of 15 years revealed by demonstration of the same type of EML4-ALK fusion gene.
Tsukamoto Y; Kanamori K; Watanabe T; Mikami K; Ieki R; Nakano T; Kajimoto K; Hirota S
Pathol Res Pract; 2014 Dec; 210(12):1112-6. PubMed ID: 25238939
[TBL] [Abstract][Full Text] [Related]
19. Calcific Miliary Brain Metastasis in Adenocarcinoma Lung Treated with Gefitinib.
Divya KP; Cherian A; Prabhakaran PK; Thomas B; Shetty K
Neurol India; 2022; 70(3):1197-1199. PubMed ID: 35864664
[TBL] [Abstract][Full Text] [Related]
20. Immunohistochemical staining for thyroid transcription factor-1: a helpful aid in discerning primary site of tumor origin in patients with brain metastases.
Srodon M; Westra WH
Hum Pathol; 2002 Jun; 33(6):642-5. PubMed ID: 12152164
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
